Corleen M. Roche
Insider
First SEC filing: Oct. 8, 2024 · Latest: Oct. 8, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2026 | IOVA | M | 49,995 | · | · | 49,995 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 6, 2026 | IOVA | F | 21,238 | $6.21 | $131,888 | 28,757 Direct | -42.48% | Disposed | 127.9% (price as of 2026-10-05) |
| Aug. 6, 2026 | IOVA | M | 49,995 | · | · | 100,005 Direct | -33.33% | Disposed | (price as of 2026-10-05) |
| March 9, 2026 | IOVA | A | 132,200 | · | · | 132,200 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 6, 2025 | IOVA | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 6, 2025 | IOVA | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 15, 2025 | CGON | A | 143,907 | · | · | 143,907 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 4, 2024 | CGON | A | 93,600 | · | · | 93,600 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 29, 2024 | CGON | P | 2,000 | $19.00 | $38,000 | 2,000 Direct | · | Acquired | 261.6% (price as of 2026-10-05) |
| Jan. 24, 2024 | CGON | A | 492,920 | · | · | 492,920 Direct | · | Acquired | (price as of 2026-10-05) |
| June 8, 2023 | IMNM | A | 58,000 | · | · | 58,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2022 | IMNM | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 28, 2021 | IMNM | A | 16,609 | · | · | 16,609 Direct | · | Acquired | (price as of 2026-10-05) |
| April 19, 2021 | IMNM | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 6, 2026 | IOVA | Restricted Stock Units | Common Stock | · | · | 49,995 | Disposed |
| March 9, 2026 | IOVA | Restricted Stock Units | Common stock | · | · | 132,200 | Acquired |
| Aug. 6, 2025 | IOVA | Restricted Stock Units | Common stock | · | · | 150,000 | Acquired |
| Aug. 6, 2025 | IOVA | Stock Option (right to buy) | Common stock | $2.58 | Aug. 6, 2035 | 300,000 | Acquired |
| April 15, 2025 | CGON | Employee Stock Option (Right to Buy) | Common Stock | $20.11 | April 14, 2035 | 143,907 | Acquired |
| Oct. 4, 2024 | CGON | Stock Option (Right to Buy) | Common Stock | $36.63 | Oct. 3, 2034 | 93,600 | Acquired |
| Jan. 24, 2024 | CGON | Stock Option | Common Stock | $19.00 | Jan. 10, 2034 | 492,920 | Acquired |
| June 8, 2023 | IMNM | Stock Option (Right to Buy) | Common Stock | $4.84 | June 8, 2033 | 58,000 | Acquired |
| June 16, 2022 | IMNM | Stock Option (Right to Buy) | Common Stock | $3.42 | June 16, 2032 | 70,000 | Acquired |
| May 28, 2021 | IMNM | Stock Option (Right to Buy) | Common Stock | $20.92 | May 28, 2031 | 16,609 | Acquired |
| April 19, 2021 | IMNM | Stock Option (Right to Buy) | Common Stock | $27.53 | April 19, 2031 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $282,051 | $50,000 | · | $2,670,236 | $89,775 | · | $4,281 | $3,096,344 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $446,357 | $31,500 | · | $9,157,973 | $196,360 | · | $13,610 | $9,845,800 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.